Aspira Women's Health Inc.
AWH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,305 | $2,404 | $2,279 | $2,349 |
| % Growth | -4.1% | 5.5% | -3% | – |
| Cost of Goods Sold | $922 | $870 | $719 | $860 |
| Gross Profit | $1,383 | $1,534 | $1,560 | $1,489 |
| % Margin | 60% | 63.8% | 68.5% | 63.4% |
| R&D Expenses | $739 | $704 | $973 | $500 |
| G&A Expenses | $1,540 | $1,961 | $2,741 | $2,443 |
| SG&A Expenses | $2,223 | $2,640 | $3,827 | $4,420 |
| Sales & Mktg Exp. | $683 | $679 | $1,086 | $1,977 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,962 | $3,344 | $4,800 | $4,920 |
| Operating Income | -$1,579 | -$1,810 | -$3,240 | -$3,431 |
| % Margin | -68.5% | -75.3% | -142.2% | -146.1% |
| Other Income/Exp. Net | -$3,313 | -$856 | $1,387 | $2,043 |
| Pre-Tax Income | -$4,892 | -$2,666 | -$1,853 | -$1,388 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,892 | -$2,666 | -$1,853 | -$1,388 |
| % Margin | -212.2% | -110.9% | -81.3% | -59.1% |
| EPS | -0.13 | -0.07 | -8.58 | -0.098 |
| % Growth | -85.7% | 99.2% | -8,655.1% | – |
| EPS Diluted | -0.13 | -0.07 | -8.58 | -0.098 |
| Weighted Avg Shares Out | 36,388 | 35,564 | 216 | 14,135 |
| Weighted Avg Shares Out Dil | 36,388 | 35,564 | 216 | 14,135 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $13 | $13 | $14 | -$53 |
| Depreciation & Amortization | $50 | $0 | $13 | $14 |
| EBITDA | -$4,829 | -$1,810 | -$1,826 | -$3,417 |
| % Margin | -209.5% | -75.3% | -80.1% | -145.5% |